BoneSwift™ Injectable Bone Graft Material — Spinal Clinical Case Series (Part 1)
BoneSwift™ is China's first independently developed pre-filled injectable bone repair material. This series presents real clinical cases demonstrating the application of BoneSwift™ in spinal bone defect repair.
Dual Certification
- China NMPA Class III medical device registration certificate
- Vietnam Class D (highest level) medical device registration certificate
Dual Indications
BoneSwift™ covers both limb bone defect repair and spinal bone defect repair, providing a comprehensive solution for orthopedic clinical practice.
Three Core Advantages Redefining Bone Repair Standards
Minimally Invasive Injection
BoneSwift™ offers excellent injectability, enabling minimally invasive implantation with reduced surgical trauma and faster postoperative recovery.
Biological Activity
Derived from natural porcine cancellous bone hydroxyapatite, BoneSwift™ promotes osteoblast proliferation and differentiation, accelerating bone tissue regeneration.
Degradation Cycle Matching
The material degradation cycle precisely synchronizes with the bone metabolism cycle, ensuring a stable and controlled repair process.
BoneSwift™ injectable bone graft material is now commercially available nationwide. Medical institutions are welcome to inquire about clinical trials and product evaluation.